KALA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Kala Bio appointed a senior scientific advisor to assess clinical assets and development strategyApr 1, 2026
- KALA BIO announces topline results from CHASE Phase 2b clinical trial evaluating KPI-012 for persistent corneal epithelial defect (PCED) did not meet primary endpointSep 29, 2025
- KALA BIO completes enrollment in CHASE clinical trial evaluating KPI-012 for persistent corneal epithelial defect (PCED)Jul 9, 2025